Evidence map›Paper›PMID 33914265›Full record

ArticleInfectious diseases and therapy2021

Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study.

María Martínez-Rebollar, Lorena De La Mora, Miriam Campistol, Bruno Cabrera, Albert Bagué, Elisa De Lazzari, Berta Torres, Ana González-Cordón, Alexy Inciarte, Juan Ambrosioni and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Infectious diseases and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

María Martínez-RebollarDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Lorena De La MoraDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Miriam CampistolDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Bruno CabreraDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Albert BaguéDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Elisa De LazzariDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Berta TorresDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Ana González-CordónDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Alexy InciarteDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Juan AmbrosioniDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Esteban MartínezDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
José L BlancoDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Xavier FornsLiver Unit, Hospital Clinic, IDIBAPS, University of Barcelona and CIBEREHD, Barcelona, Spain.
Jordi BlanchPsychiatry and Psychology Department, Hospital Clinic and CIBERSAM, Barcelona University, Barcelona, Spain.
Josep MallolasDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain.
Montserrat LagunoDepartment of Infectious Diseases, HIV Unit, Hospital Clinic and IDIBAPS, Barcelona University, Barcelona, Spain. mlaguno@clinic.cat.ORCID http://orcid.org/0000-0002-7798-6352
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESCentro de Investigación Biomédica en Red · ESCentro de Investigación Biomédica en Red de Salud Mental · ESHospital Clínic de Barcelona · ES

Funding

Abvvie The medical writing assistance for this manuscript was funded by AbbVie in the context of a contract of service.Ministerio de Economía, Industria y Competitividad, Gobierno de España PI18/00583
6 · The paper itself

Abstract

introductionThe objective of the present study is to describe the incidence of recently acquired hepatitis C (RAHCV) in a large cohort of people living with HIV (PLWHIV) and sexualized drug use and other related risk behaviours.

methodsObservational study including all PLWHIV with a RAHCV episode between June 2005 and December 2019 at the Hospital Clinic of Barcelona, Spain. Incidence of RAHCV was determined per person calendar year (py) in those patients who were HCV RNA negative. Data were collected on high-risk sexual practices for HCV transmission focused on gay, bisexual and other men having sex with men (gbMSM).

resultsA total of 340 RAHCV were diagnosed in 290 PLWHIV; 274 (94%) of them were gbMSM and developed 324 RAHCV, mainly since 2010 (90%). Overall incidence rate (IR) of RAHCV in gbMSM was 0.10 py (95% CI 0.09-0.11), with a 40% decreased observed since 2017 (IR 0.06, 95% CI 0.03-0.09 in 2019). Sixty reinfections were detected in 50 gbMSM (n = 244, 20%). The overall reinfection IR was 0.17 per py (95% CI 0.12-0.23) and the proportion of reinfection among total RAHCV increased to 47% cases in 2019, mainly in patients engaged in sexualized substance use (76%), unprotected anal intercourse (94%), sex partying (80%), fisting (43%), slamming (14%) and 60% of concomitant sexually transmitted infections (STIs).

conclusionsDespite RAHCV incidence decline in our cohort since 2017, HCV reinfection increased. High sexualized substance use and other risk behaviours are described in this context, indicating the need for public health tailored strategies to reduce this transmission and achieve HCV microelimination in gbMSM living with HIV.

Indexed as

GbMSMHCVHIVIncidenceReinfectionSexualized substance use

Identifiers

PMID33914265
PMCPMC8322221
OpenAlexW3159334132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.